D
Cullinan Therapeutics, Inc. CGEM
$8.74 -$0.33-3.64% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Net Income -30.56% -100.17% -3.51% -30.47% 35.91%
Total Depreciation and Amortization 0.00% 0.00% -5.00% -4.94% 5.56%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 49.36% 167.96% -12.44% 17.89% -17.22%
Change in Net Operating Assets 69.63% 45.65% 1,117.68% 75.30% -600.34%
Cash from Operations -12.83% -102.01% 0.01% -17.05% 25.00%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 184.08% -68.98% 146.27% -1,622.43% -15.56%
Cash from Investing 184.08% -68.98% 146.27% -1,628.59% -14.67%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- 537.90% 1,668.75% 589.70% --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -10,633.33% --
Cash from Financing -- 537.90% 1,083.04% 579.23% -39.35%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 73.77% -156.81% 83.20% 107.01% 28.86%